Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-039609
Filing Date
2022-02-14
Accepted
2022-02-14 08:01:53
Documents
1
Group Members
BOSTON BIOTECH VENTURES, LLCOCHA LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d283352dsc13ga.htm SC 13G/A 83231
  Complete submission text file 0001193125-22-039609.txt   84614
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address
Bancel Stephane (Filed by) CIK: 0001443340 (see all company filings)

Type: SC 13G/A

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Subject) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90749 | Film No.: 22625368
SIC: 2836 Biological Products, (No Diagnostic Substances)